Lymphatic endothelial cells, lymphangiogenesis, and extracellular matrix

Area of Science:

• Molecular biology
• Cell biology
• Physiology

Background:

• Lymphangiogenesis, the formation of new lymphatic vessels, is critical in wound healing, lymphedema, and tumor metastasis.
• The interplay between lymphatic endothelial cells (LECs) and the extracellular matrix (ECM) microenvironment is central to lymphangiogenesis.
• Understanding these interactions is vital for addressing lymphatic-associated disorders.

Purpose of the Study:

• To review the molecular regulation of lymphangiogenesis.
• To highlight the role of ECM molecules and signaling pathways in LEC function.
• To identify potential therapeutic targets for lymphatic disorders.

Main Methods:

• Review of existing literature on lymphangiogenesis molecular regulation.
• Analysis of key molecules involved in LEC growth, migration, and survival.
• Discussion of signaling pathways controlling embryonic and pathological lymphangiogenesis.
• Mention of techniques for visualizing lymphatic structures, such as novel molecular markers (e.g., LYVE-1) and tracer injections.

Main Results:

• ECM molecules and remodeling are key regulators of lymphangiogenesis.
• Specific molecules (hyaluronan, integrins, reelin, IL-7, matrix metalloproteinases) are fundamental for LEC growth, migration, tube formation, and survival.
• Lymphangiogenesis is controlled by multiple signaling pathways including VEGF-C/-D/VEGFR-3, Prox-1, and others.
• Novel molecular markers and techniques aid in understanding lymphatic structure and function.

Conclusions:

• Recognizing the functions of ECM and LEC molecules is crucial for understanding tissue changes in lymph circulation.
• This knowledge can guide the development of therapeutic strategies for lymphatic-associated disorders.
• Further research into cytokines, chemokines, and differentiation factors will enhance our understanding.